Browse By

Daily Archives: October 11, 2023

Non-Dilutive Investment Is Back In Vogue

–News Direct– By John Biggs In the wake of a significant reduction in U.S. venture capital (VC) funding, which dropped from $345 billion in 2021 to $238 billion in 2022, there has been a marked shift towards non-dilutive funding among tech companies. Distinct from traditional

AI Could Make Many Jobs Obsolete Amesite (NASDAQ: AMST) Is Helping Empower The Workforce Of The Future Through Its AI-Powered Platform

–News Direct– By Meg Flippin, Benzinga With the economy slowing and advances in artificial intelligence (AI) technology accelerating, reskilling is becoming an important component of any companys success. AI and its accompanying automation could render many jobs obsolete. But it's not just companies that stand

Oncotelic Therapeutics (OTCQB: OTLC) Lead Immunotherapy Candidate For Treating Deadly Cancers, OT-101, Could Hold Potential Applications In Multiple Multi-Billion Dollar Markets

–News Direct– By Faith Ashmore, Benzinga Oncotelic Therapeutics (OTCQB: OTLC) is a clinical-stage biopharmaceutical company. Its primary focus is on developing innovative drugs for oncology and infectious disease and aging. OT-101 is the companys lead immuno-oncology drug candidate, showing promise in the treatment of deadly